PG — The Procter & Gamble Company

The market is cautious but not panicked. PG has lagged the S&P 500 over the past year and several analysts trimmed targets after the July earnings miss, yet the consensus remains a split Buy/Hold with an average target near $158, and the defensive dividend story is intact. That balance keeps sentiment neutral.

Revenue has been stable with slight acceleration at the full-year level: FY26 revenue was ~$87.0B vs ~$84.3B in FY25 and ~$84.0B in FY24. The important trend is margin compression through FY26: operating margin fell from 26.2% in Q1 FY26 to 18.6% in Q4 FY26, and diluted EPS fell from $1.95 to $1.26. Q4 FY26 operating margin of 18.6% was ~220bps below the year-ago 20.9%. This looks like a commodity-cost squeeze rather than a demand collapse — Q4 revenue still grew ~1.5% YoY and quarterly FCF was $4.87B. The open question is whether Q4 FY26 is the trough or the start of a longer margin drag.

At $143.14, PG trades at 21.2x trailing EPS of $6.62 and roughly 20.5x forward EPS of $6.98. That is below its own 5-year average P/E of 24.18 and its 5-year average P/S of 4.42 versus 3.91 now, so it is not expensive vs its own history. But with EPS growth of only ~1-5% expected, the PEG is meaningless/unflattering, so this is a fair quality valuation, not a bargain.

The market is pricing near-zero growth and waiting for proof the commodity-cost hit is over. At $143, PG is not pricing in a recovery. If Q1 FY27 shows operating margin back above 22% and EPS near $1.80+, the stock should re-rate toward $155-160. If margins stay at Q4 FY26 levels, fair value is close to the current price and downside toward the $137-140 zone is possible.

As of 2026-08-27, RSI was 42.8 — weak but not oversold. Price was 1.3% below the 20-day, 2.8% below the 50-day, and 3.0% below the 200-day moving average, so the trend is down. PG is hugging the low end of its 52-week range; a sustained move back above the $145 area would be the first stabilization sign, otherwise $137.6 is the key floor to watch. For an entry-minded investor, there is no urgency to catch a falling knife.

• Crude oil near $100/bbl is raising feedstock and logistics costs; PG cited roughly a $1B annual after-tax headwind concentrated in fiscal Q4 2026.
• Persistent inflation and high rates are squeezing lower-income consumers, increasing trade-down from premium brands to private label.
• PG's low beta (0.38) and 2.9% dividend yield make it a defensive rotation candidate when growth fears rise, but that limits upside in strong risk-on markets.
• Currency/FX swings can affect international revenue translation, a headwind that is not fully visible in the US-dollar financials.
• Geopolitical and tariff-related supply-chain disruptions add cost and complexity to P&G's global manufacturing footprint.

• Q1 FY2027 earnings (expected late October 2026): the market needs to see operating margins recover from Q4's 18.6% and organic volume turn positive.
• Closing and integration of the $3.8B L Catterton asset acquisition; update on whether it adds real growth or just scale.
• A sustained decline in crude oil/commodity prices would directly reverse the biggest current margin headwind.
• The company's 70-year dividend-increase streak and any new capital return authorizations support the total-return case.

• Commodity costs remain elevated or rise further, keeping Q4 FY26-level margin compression in place.
• Consumers trade down more aggressively, causing volume declines that pricing can no longer offset.
• The $3.8B cash acquisition fails to deliver expected growth or integration issues tie up capital with limited return.
• If EPS stays flat, the stock could de-rate further despite being below its historical average multiple.

PG is a high-quality defensive business with strong pricing power, consistent free cash flow, and a 70-year dividend-growth record, but the current earnings trough from commodity costs is real. At $143, the risk/reward is balanced rather than compelling: a good hold for current owners, and for new investors worth waiting for either margin stabilization evidence or a better entry near the 52-week low. This is analysis, not personalized investment advice.

I applied a 22.5x P/E multiple to next-fiscal-year estimated EPS of $6.98 — a justified premium to the current 21.2x trailing multiple due to PG's high ROIC, strong FCF, and negative accruals, but below its 5-year average P/E of 24.18 given ~5% growth. This gives ~$157; cross-checking TTM free cash flow of ~$15.9B at a 4.2% FCF yield gives ~$159, so I set fair value at $158.00.